Apolipoprotein e derived HDL mimetic peptide ATI-5261 promotes nascent HDL formation and reverse cholesterol transport in vitro

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 10, 2014, Pages 1498-1512

  Hafiane, Anouar ^a   Bielicki, John K ^b   Johansson, Jan O ^c   Genest, Jacques ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c Artery Therapeutics ^*  (United States)

Author keywords

ABCA1; ABCG1; Cholesterol efflux; HDL; Reverse cholesterol transport; SR BI

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; ATI 5261 PEPTIDE; CHOLESTEROL ESTER; DITHIOTHREITOL; HIGH DENSITY LIPOPROTEIN; MIFEPRISTONE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BHK CELL LINE; BIOGENESIS; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DESORPTION; ELECTROPHORETIC MOBILITY; GENE OVEREXPRESSION; IMMUNOBLOTTING; LIVER CELL; MACROPHAGE; NONHUMAN; OLIGOMERIZATION; PARTICLE SIZE; PHOSPHOLIPID TRANSFER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE CHOLESTEROL TRANSPORT;

EID: 84910051768     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.07.018     Document Type: Article

References (64)

1. E. Di Angelantonio, N. Sarwar, and P. Perry et al. Major lipids, apolipoproteins, and risk of vascular disease JAMA 302 18 2009 1993 2000
2. B.F. Voight, G.M. Peloso, and M. Orho-Melander et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study Lancet 380 9841 2012 572 580
3. G.G. Schwartz, A.G. Olsson, and M. Abt et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome N. Engl. J. Med. 367 22 2012 2089 2099
4. W.E. Boden, M.S. Sidhu, and P.P. Toth The therapeutic role of niacin in dyslipidemia management J. Cardiovasc. Pharmacol. Ther. 19 2 Mar 2014 141 158
5. A. Hafiane, S. Kellett, and J. Genest Treatment options for low high-density lipoproteins Curr. Opin. Endocrinol Diabetes Obes. 21 2 Apr 2014 134 139
6. G.M. Anantharamaiah, V.K. Mishra, and D.W. Garber et al. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides J. Lipid Res. 48 9 Sep 2007 1915 1923 (Pubitemid 47360611)
7. Y. Zheng, A.B. Patel, V. Narayanaswami, G.L. Hura, B. Hang, and J.K. Bielicki HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution Biochemistry 50 19 2011 4068 4076
8. M. Ditiatkovski, W. D'Souza, and R. Kesani et al. An apolipoprotein A-I mimetic peptide designed with a reductionist approach stimulates reverse cholesterol transport and reduces atherosclerosis in mice PLoS ONE 8 7 2013 e68802
9. J.K. Bielicki, H. Zhang, and Y. Cortez et al. A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice J. Lipid Res. 51 6 Jun 2010 1496 1503
10. A.T. Remaley, F. Thomas, and J.A. Stonik et al. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway J. Lipid Res. 44 4 Apr 2003 828 836 (Pubitemid 37279685)
11. C.R. White, L.E. Smythies, D.K. Crossman, M.N. Palgunachari, G.M. Anantharamaiah, and G. Datta Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F Arterioscler. Thromb. Vasc. Biol. 32 11 Nov 2012 2631 2639
12. Y. Zheng, A.B. Patel, V. Narayanaswami, and J.K. Bielicki Retention of alpha-helical structure by HDL mimetic peptide ATI-5261 upon extensive dilution represents an important determinant for stimulating ABCA1 cholesterol efflux with high efficiency Biochem. Biophys. Res. Commun. 441 1 2013 71 76
13. N. Wang, D.L. Silver, C. Thiele, and A.R. Tall ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein J. Biol. Chem. 276 26 2001 23742 23747
14. M. Denis, B. Haidar, M. Marcil, M. Bouvier, L. Krimbou, and J. Genest Jr. Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1) J. Biol. Chem. 279 9 2004 7384 7394 (Pubitemid 38294614)
15. L. Krimbou, M. Denis, B. Haidar, M. Carrier, M. Marcil, and J. Genest Jr. Molecular interactions between apoE and ABCA1: impact on apoE lipidation J. Lipid Res. 45 5 May 2004 839 848 (Pubitemid 38552853)
16. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1 Nov 1951 265 275
17. J.F. Oram, A.M. Vaughan, and R. Stocker ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol J. Biol. Chem. 276 43 2001 39898 39902
18. A. Hafiane, B. Jabor, I. Ruel, J. Ling, and J. Genest High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes Am. J. Cardiol. 113 2 2014 249 255
19. S. Nandi, L. Ma, and M. Denis et al. ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity J. Lipid Res. 50 3 Mar 2009 456 466
20. K. Gaus, M. Rodriguez, and K.R. Ruberu et al. Domain-specific lipid distribution in macrophage plasma membranes J. Lipid Res. 46 7 Jul 2005 1526 1538 (Pubitemid 43109818)
21. B.F. Asztalos, C.H. Sloop, L. Wong, and P.S. Roheim Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations Biochim. Biophys. Acta 1169 3 1993 291 300 (Pubitemid 23264886)
22. M. Dobiasova, and J. Frohlich Measurement of fractional esterification rate of cholesterol in plasma depleted of apoprotein B containing lipoprotein: methods and normal values Physiol. Res. 45 1 1996 65 73 (Pubitemid 26091968)
23. J. Frohlich, and M. Dobiasova Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography Clin. Chem. 49 11 Nov 2003 1873 1880 (Pubitemid 37340322)
24. D. Bailey, I. Ruel, and A. Hafiane et al. Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis J. Lipid Res. 51 4 Apr 2010 785 797
25. F. Zimetti, G.K. Weibel, M. Duong, and G.H. Rothblat Measurement of cholesterol bidirectional flux between cells and lipoproteins J. Lipid Res. 47 3 Mar 2006 605 613 (Pubitemid 43345601)
26. E.T. Alexander, C. Vedhachalam, and S. Sankaranarayanan et al. Influence of apolipoprotein A-I domain structure on macrophage reverse cholesterol transport in mice Arterioscler. Thromb. Vasc. Biol. 31 2 Feb 2011 320 327
27. B.K. Nordskog, J.W. Reagan Jr., and R.W. St Clair Sterol synthesis is up-regulated in cholesterol-loaded pigeon macrophages during induction of cholesterol efflux J. Lipid Res. 40 10 Oct 1999 1806 1817 (Pubitemid 29477251)
28. P.G. Yancey, M. de la Llera-Moya, and S. Swarnakar et al. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI J. Biol. Chem. 275 47 2000 36596 36604 (Pubitemid 32002059)
29. T.J. Nieland, M. Penman, L. Dori, M. Krieger, and T. Kirchhausen Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI Proc. Natl. Acad. Sci. U. S. A. 99 24 2002 15422 15427 (Pubitemid 35403950)
30. J.D. Smith Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis Curr. Opin. Investig. Drugs 11 9 Sep 2010 989 996
31. S.W. Law, G. Gray, and H.B. Brewer Jr. cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I Biochem. Biophys. Res. Commun. 112 1 1983 257 264
32. C. Vedhachalam, V. Narayanaswami, and N. Neto et al. The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins Biochemistry 46 10 2007 2583 2593 (Pubitemid 46417902)
33. M. Denis, B. Haidar, M. Marcil, M. Bouvier, L. Krimbou, and J. Genest Characterization of oligomeric human ATP binding cassette transporter A1. Potential implications for determining the structure of nascent high density lipoprotein particles J. Biol. Chem. 279 40 2004 41529 41536 (Pubitemid 39313594)
34. I. Iatan, D. Bailey, and I. Ruel et al. Membrane microdomains modulate oligomeric ABCA1 function: impact on apoAI-mediated lipid removal and phosphatidylcholine biosynthesis J. Lipid Res. 52 11 Nov 2011 2043 2055
35. H.H. Hassan, D. Bailey, and D.Y. Lee et al. Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I: implications for determining cellular kinetics of nascent high density lipoprotein biogenesis J. Biol. Chem. 283 17 2008 11164 11175
36. A.M. Vaughan, and J.F. Oram ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL J. Lipid Res. 47 11 Nov 2006 2433 2443 (Pubitemid 44936105)
37. Y. Liu, and C. Tang Regulation of ABCA1 functions by signaling pathways Biochim. Biophys. Acta 1821 3 Mar 2012 522 529
38. S. Diditchenko, A. Gille, and I. Pragst et al. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux Arterioscler. Thromb. Vasc. Biol. 33 9 Sep 2013 2202 2211
39. K.O. Nagata, C. Nakada, R.S. Kasai, A. Kusumi, and K. Ueda ABCA1 dimer-monomer interconversion during HDL generation revealed by single-molecule imaging Proc. Natl. Acad. Sci. U. S. A. 110 13 2013 5034 5039
40. D. Trompier, M. Alibert, S. Davanture, Y. Hamon, M. Pierres, and G. Chimini Transition from dimers to higher oligomeric forms occurs during the ATPase cycle of the ABCA1 transporter J. Biol. Chem. 281 29 2006 20283 20290 (Pubitemid 44065803)
41. H. Hara, and S. Yokoyama Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol J. Biol. Chem. 266 5 1991 3080 3086 (Pubitemid 21909177)
42. A. Mulya, J.Y. Lee, and A.K. Gebre et al. Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL J. Lipid Res. 49 11 Nov 2008 2390 2401
43. C. Vedhachalam, P.T. Duong, and M. Nickel et al. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles J. Biol. Chem. 282 34 2007 25123 25130 (Pubitemid 47347535)
44. M.G. Sorci-Thomas, and M.J. Thomas High density lipoprotein biogenesis, cholesterol efflux, and immune cell function Arterioscler. Thromb. Vasc. Biol. 32 11 Nov 2012 2561 2565
45. M.C. Phillips New insights into the determination of HDL structure by apolipoproteins: thematic review series: high density lipoprotein structure, function, and metabolism J. Lipid Res. 54 8 Aug 2013 2034 2048
46. K. Nagao, M. Hata, and K. Tanaka et al. The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles Biochim. Biophys. Acta 1841 1 Jan 2014 80 87
47. L. Yvan-Charvet, N. Wang, and A.R. Tall Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses Arterioscler. Thromb. Vasc. Biol. 30 2 Feb 2010 139 143
48. M.B. Fessler, and J.S. Parks Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling J. Immunol. 187 4 2011 1529 1535
49. H.H. Hassan, M. Denis, L. Krimbou, M. Marcil, and J. Genest Cellular cholesterol homeostasis in vascular endothelial cells Can. J. Cardiol. 22 Suppl. B Feb 2006 35B 40B (Pubitemid 44963570)
50. M. de la Llera-Moya, D. Drazul-Schrader, B.F. Asztalos, M. Cuchel, D.J. Rader, and G.H. Rothblat The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages Arterioscler. Thromb. Vasc. Biol. 30 4 Apr 2010 796 801
51. A.A. Sethi, J.A. Stonik, and F. Thomas et al. Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides J. Biol. Chem. 283 47 2008 32273 32282
52. A.D. Dergunov Sequence-specific apolipoprotein A-I effects on lecithin:cholesterol acyltransferase activity Mol. Cell. Biochem. 378 1-2 Jun 2013 283 290
53. L. Calabresi, and G. Franceschini Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans Trends Cardiovasc. Med. 20 2 Feb 2010 50 53
54. G.M. Anantharamaiah, J.L. Jones, and C.G. Brouillette et al. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine J. Biol. Chem. 260 18 1985 10248 10255 (Pubitemid 16246560)
55. B.H. Chung, G.M. Anatharamaiah, C.G. Brouillette, T. Nishida, and J.P. Segrest Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function J. Biol. Chem. 260 18 1985 10256 10262 (Pubitemid 16246561)
56. D.W. Garber, Y.V. Venkatachalapathi, and K.B. Gupta et al. Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties Arterioscler. Thromb. 12 8 Aug 1992 886 894
57. X. Chen, C. Burton, and X. Song et al. An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration Int. J. Biol. Sci. 5 5 2009 489 499
58. D.J. Bolin, and A. Jonas Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding J. Biol. Chem. 271 32 1996 19152 19158 (Pubitemid 26271578)
59. J.A. de Souza, C. Vindis, and B. Hansel et al. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity Atherosclerosis 197 1 Mar 2008 84 94 (Pubitemid 351273276)
60. John K. Bielicki BA, Jan Johansson, and Salman Azhar Abstract 1093: the novel apolipoprotein mimetic peptide ATI-5261 induces Preβ-1 HDL formation in human plasma via a highly specific mechanism involving distinct - HDL subpopulations Circulation 120 2009 S445 (http://circ.ahajournals.org/cgi/ content/meeting
61. W.J. Johnson, F.H. Mahlberg, G.H. Rothblat, and M.C. Phillips Cholesterol transport between cells and high-density lipoproteins Biochim. Biophys. Acta 1085 3 1991 273 298
62. X. Song, P. Fischer, X. Chen, C. Burton, and J. Wang An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI Int. J. Biol. Sci. 5 7 2009 637 646
63. N. Yang, S. Yao, M. Wang, P. Jiao, Y. Zhang, and S. Qin Apolipoprotein A-I mimetic peptide reverse D-4F improves the biological functions of mouse bone marrow-derived late EPCs via PI3K/AKT/eNOS pathway Mol. Cell. Biochem. 377 1-2 May 2013 229 236
64. C. Besler, K. Heinrich, and L. Rohrer et al. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease J. Clin. Invest. 121 7 Jul 2011 2693 2708